Accordingly, the reduction of α-SMA and PD-L1 expression, in tumour tissues, indicates that BBIT20 mitigates immunosuppression, fostering a tumour microenvironment more conducive to the activation and effectiveness of immune cells. This evidence concerns the gene CD274 and neoplasm.